- Latest news▼
-
23:22, September 7 How Can a Fly’s Brain Help Us Understand Human Behavior?
-
21:18, September 7 How the Pursuit of Perfect Sleep Can Keep You Awake
-
08:37, September 7 Weight-Loss Drug May Affect Aging: Scientists Discover an Unexpected Effect of Semaglutide
-
20:53, September 5 npj Science of Food: A Spoonful of Vegetable Oil Before a Carb-Rich Meal May Blunt Blood Sugar Spikes
-
13:26, September 5 In the U.S., Prescriptions for Obesity Drugs for Children Under 12 Increased 310-Fold in Seven Years
-
23:20, September 4 TCTV: New Drug Doubles Survival in Lung Cancer
-
11:10, September 4 SB: The Rule of Drinking Eight Glasses of Water a Day Has No Scientific Basis
-
08:46, September 4 JID: Popular Weight-Loss Drugs May Increase the Risk of Male Pattern Hair Loss by 7%
-
22:46, September 3 At-Home Urine Test Could Detect Most Bladder Cancer Cases, Study Finds
-
20:38, September 3 Alcohol-Related Cancer Deaths Double in the U.S. as the Number of Such Deaths Rises Over 33 Years
-
18:29, September 3 An Unexpected Paradox: Both Very Low and Very High Testosterone Levels May Be Equally Dangerous for the Heart
-
16:11, September 3 The Independent: Aging Is the Main Risk Factor for Cancer
-
14:13, September 3 CC: Age-Related Changes in Memory May Begin as Early as 50
-
08:34, September 3 Scientists Find Who May Benefit More from Coffee in Terms of Parkinson’s Disease Risk
-
23:37, September 2 LDE: Popular Diabetes Drugs Linked to Risk of a Dangerous Complication in Certain Patients
All materials
New drug shows promising results against COVID-19
Merck & Co. Pharmaceutical Company and US Laboratory have announced promising results in new trials of a new drug against COVID-19. The drug helps to reduce the patient's viral load, BusinessWire reported.
“At a time where there is unmet need for antiviral treatments against SARS-CoV-2, we are encouraged by these preliminary data” said Dr. Wendy Painter, Chief Medical Officer of Ridgeback Biotherapeutics.
Merck & Co. stopped working on two candidate coronavirus vaccines in January, but continued research into two drugs to treat coronavirus, including a drug called Molnupiravir, developed in collaboration with Ridgeback Biotherapeutics.
This drug significantly reduced the viral load of patients after 5 days of treatment. The second phase of trials of the new drug was carried out among 202 non-hospitalized people with symptoms of Covid-19. None of the four reported adverse events were related to the use of this drug, Ridgeback said.
Merck is also working on another oral drug for Covid-19 treatment called MK-711. Preliminary results of clinical trials of the drug show a more than 50% reduction in the risk of death or respiratory disease in patients hospitalized with moderate to severe COVID-19.
Follow NEWS.am Medicine on Facebook and Twitter
- Most read
month
week
day
- An Unexpected Paradox: Both Very Low and Very High Testosterone Levels May Be Equally Dangerous for the Heart 958
- Alcohol-Related Cancer Deaths Double in the U.S. as the Number of Such Deaths Rises Over 33 Years 879
- The Independent: Aging Is the Main Risk Factor for Cancer 860
- CC: Age-Related Changes in Memory May Begin as Early as 50 848
- At-Home Urine Test Could Detect Most Bladder Cancer Cases, Study Finds 839
- Scientists Find Who May Benefit More from Coffee in Terms of Parkinson’s Disease Risk 715
- SB: The Rule of Drinking Eight Glasses of Water a Day Has No Scientific Basis 82
- JID: Popular Weight-Loss Drugs May Increase the Risk of Male Pattern Hair Loss by 7% 79
- npj Science of Food: A Spoonful of Vegetable Oil Before a Carb-Rich Meal May Blunt Blood Sugar Spikes 76
- Weight-Loss Drug May Affect Aging: Scientists Discover an Unexpected Effect of Semaglutide 76
- In the U.S., Prescriptions for Obesity Drugs for Children Under 12 Increased 310-Fold in Seven Years 74
- How the Pursuit of Perfect Sleep Can Keep You Awake 74
- TCTV: New Drug Doubles Survival in Lung Cancer 74
- How Can a Fly’s Brain Help Us Understand Human Behavior? 69
- Find us on Facebook
- Poll